The Genetic and Rare Diseases (GARD) Information Center provides free, accessible resources for the millions of Americans affected by over 10,000 rare diseases. By offering reliable information and dedicated specialists, the center helps patients navigate the common challenges of obtaining a diagnosis and accessing support for conditions that are individually rare but collectively widespread.
Bridging the Gap for Rare Disease Communities
While an estimated 10,000 rare diseases exist, the individuals living with these conditions often encounter a shared set of obstacles. According to the Genetic and Rare Diseases (GARD) Information Center, these hurdles frequently include difficulties in securing an accurate diagnosis, finding relevant resources, and accessing clear information about their health. The center’s mission is to address these systemic challenges by acting as a centralized hub for the rare disease community.
The organization provides support through its website and via dedicated Information Specialists located in its Contact Center. By delivering reliable and easy-to-understand data, the center aims to assist those who may otherwise struggle to find guidance for conditions that are often poorly understood by the general medical community.
Understanding Neurodegenerative Prion Disease
The complexity of rare diseases is exemplified by conditions such as fatal insomnia, a neurodegenerative prion disease. The disease is categorized as a prion disease of the human brain, which typically results in the hallmark symptom of trouble sleeping.
Clinical Challenges and Diagnostic Complexity
Diagnosing rare conditions like fatal insomnia requires specialized medical insight. Symptoms often include ataxia, double vision, cachexia, and high blood pressure. In the sporadic form of the disease, patients often present with double vision and prolonged constipation.
| Condition Aspect | Clinical Details |
|---|---|
| Average Duration | 18 months |
| Usual Onset | 45–50 years old |
| Treatment | Supportive care only |
| Frequency | 70 families known to carry the gene; 37 sporadic cases (as of 20 September 2022) |
The rarity of such conditions creates a pattern where patients may face significant delays in receiving a diagnosis. Whether a patient is dealing with a genetically inherited condition or a sporadic case, the lack of disease-modifying treatments highlights the ongoing need for the resources provided by organizations like GARD. For those impacted by rare and complex neurodegenerative disorders, the path toward understanding their diagnosis remains a challenge that requires both specialized medical attention and access to accurate, reliable information.
If you are experiencing symptoms or seeking information regarding a rare medical condition, please consult your healthcare provider.
